相关实验视频

Updated: Jun 21, 2025

Embryonic Stem Cell-Derived Endothelial Cells for Treatment of Hindlimb Ischemia

Embryonic Stem Cell-Derived Endothelial Cells for Treatment of Hindlimb Ischemia

Published on: January 23, 2009

来自诱导多能干细胞-大脑髓干细胞的大型细胞外囊通过ERK/MAPK增强肢体血管生成

Ziyu Huang^1,2, Zhengsheng Chen^1,2, Teng Ye^1,2

¹Institute of Microsurgery on Extremities, Department of Orthopedic Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, 600# Yishan Road, Shanghai 200233, China.

Nanomedicine (London, England)

|July 16, 2024

概括

来自诱导多能干细胞-介质干细胞 (iMSCs-lEVs) 的大型细胞外囊 (EVs) 有效地治疗下肢缺血症. 这些EV通过ERK/MAPK通路促进血管生成,增强功能恢复.

科学领域:

再生医学是一种再生医学.
血管生物学血管生物学
干细胞疗法是一种干细胞疗法.

背景情况:

下肢缺血性疾病 (LLID) 是一种严重的疾病,治疗选择有限.
细胞外囊泡 (EVs) 正在成为细胞间通信的关键媒介.
介酶干细胞 (MSCs) 显示出治疗潜力,但它们的机制,特别是通过EVs,需要进一步阐明.

研究的目的:

研究由诱导的多能干干细胞-介质干细胞 (iMSCs) 所衍生的大型细胞外囊泡 (lEVs) 对下肢缺血性疾病 (LLID) 的治疗效果.
探索iMSCs-lEVs在促进组织修复和功能恢复方面的潜在分子机制.
评估iMSCs-lEVs对血管生成和内皮细胞功能的影响.

主要方法:

组织学分析 (H&E,免疫光) 来评估肌肉病理.
在体外测试包括伤口愈合,管形成,RT-qPCR和ELISA以评估细胞反应.
奥米克分析 (RNA测序,蛋白质组分析) 以确定涉及的分子途径.

主要成果:

在缺血模型中,iMSCs-lEVs显著缓解肌肉损伤,改善下肢功能.
在体外,iMSCs-lEVs增强了人类微血管内皮细胞 (HMEC-1) 的增殖,迁移和血管生成.
确定ERK/MAPK信号通路是通过iMSCs-lEVs调节促进血管生成的关键调解器.

结论:

iMSCs-lEVs在下肢缺血性疾病中显示出显著的治疗潜力.
通过调节ERK/MAPK信号通路来调节iMSCs-lEVs的益血管性作用.
这些发现支持iMSCs-lEVs的发展,作为治疗缺血病的无细胞治疗策略.

关键词:

血管新生是因为血管新生.人类微血管内皮细胞在 iPSC-MSCs 中使用.大型的细胞外囊泡.肢体缺血症肢体缺血症

更多相关视频

Author Spotlight: Advancements in iPSCs and Genetic Disease Research

Author Spotlight: Advancements in iPSCs and Genetic Disease Research

Published on: October 20, 2023

Programming Stem Cells for Therapeutic Angiogenesis Using Biodegradable Polymeric Nanoparticles

Programming Stem Cells for Therapeutic Angiogenesis Using Biodegradable Polymeric Nanoparticles

Published on: September 27, 2013

相关概念视频

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...